PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'U.S. Medical Affairs, Genentech, Inc., South San Francisco, CA, USA.\', \'Safety and Risk Management, Product Development, F. Hoffmann-La Roche AG, Basel, Switzerland.\', \'Personalized Healthcare Data Science, Global Product Development, Genentech, South San Francisco, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/oncolo/oyab083
?:doi
?:hasPublicationType
?:journal
  • The oncologist
is ?:pmid of
?:pmid
?:pmid
  • 35274714
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35274714>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35274714>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all